Putative Biomarkers Of Response To Anti-Pd-1 Therapy In Metastatic Castration-Resistant Prostate Cancer (Mcrpc).

JOURNAL OF CLINICAL ONCOLOGY(2021)

引用 0|浏览0
暂无评分
摘要
155Background: Metastatic castration resistant prostate cancer (mCRPC) is a heterogeneous disease in which molecular stratification is needed to improve clinical outcomes. Targeting programmed cell...
更多
查看译文
关键词
prostate cancer,putative biomarkers,castration-resistant
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要